Approximately 200.000 Dutch patients suffer from neuromuscular disorders (NMDs). Neuromuscular junctions (NMJs) are highly specialized structures that enable motor neurons to communicate with muscle fibers to establish muscle contraction. NMJ pathophysiology underlies muscle dysfunction in a range of NMDs such as amyotrophic lateral sclerosis, myasthenia gravis and Duchenne muscular dystrophy. The recent development of advanced … Read more
The brain is the most complex organ in the human body. Today, it remains a challenge to effectively treat patients suffering from a brain disorder such as Alzheimer’s disease, multiple sclerosis, or stroke. A brain disorder has a huge impact on patients, their caretakers, and society but effective drugs remain an unmet clinical need. … Read more
PimBio has received financial support from the Dutch Ministry of Economic Affairs and Climate under the program “De Subsidieregeling MKB Innovatiestimulering Topsectoren Zuid-Nederland 2015”. The project covers feasibility study for additive manufacturing microfluidica for cell culture designated with the acronym ‘ADAM’. Goal of the project is to obtain insight in the technological feasibility to prototype … Read more
PimBio has received MIT Zuid funding for innovative SMEs. The aim of the project is to evaluate feasibility of developing a novel ‘Microfluidic microtissue in vitro culture’ platform designated with the acronym ‘MUSIC’.
PimBio partner in €3.16M EU Interreg project TTD Cardiovascular diseases come with major personal and societal implications. Within the Interreg Flanders- The Netherlands project Trans Tech Diagnostics (TTD) this public-private consortium of Maastricht University (CARIM, lead partner), University Hasselt (BIOMED), VITO and TSG Innoteq focuses on the development of innovative diagnostic alternatives that allow for … Read more
The Laboratory of the Innovative Testing Research Group of HU University of Applied Sciences Utrecht (The Netherlands) in collaboration with partners has obtained SIA RAAK-PRO funding for development, optimization and implementation of two innovative intestinal in vitro models for evaluation of the safety and efficacy of food ingredients. PimBio B.V. has developed a microfluidic device … Read more
PimBio has started to working together with Axxicon Moulds Eindhoven on the organ-on-a-chip application field and feels that we can combine our competences with engineering expertise of Axxicon to be proactive in this challenging new application field and work together towards serving our customers.